Hassan, Iftekhar <br/><br/>
Vitamin B₂: a promising adjuvant in cisplatin based chemoradiotherapy by cellular redox management.  [electronic resource] 

 -  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association  Sep 2013 
 - 715-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-6351 
<br/><br/><label>Standard No.: </label>10.1016/j.fct.2013.07.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chemoradiotherapy, Adjuvant--adverse effects<br/>Cisplatin--adverse effects<br/>Humans<br/>Neoplasms--metabolism<br/>Oxidation-Reduction<br/>Photosensitizing Agents--adverse effects<br/>Phototherapy--adverse effects<br/>Radiation-Sensitizing Agents--adverse effects<br/>Reactive Nitrogen Species--antagonists & inhibitors<br/>Reactive Oxygen Species--antagonists & inhibitors<br/>Riboflavin--adverse effects